In this week’s New England Journal of Medicine (NEJM), there is an interesting article entitled, “Contingent knowledge and looping effects — a 66-year-old man with PSA-detected prostate cancer and regrets”. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: "looping", context, contingent, data, interpretation, knowledge | 7 Comments »
A report on the UroToday web site has addressed a presentation given this week at the ESMO 2018 Congress in Munich, Germany, that is relevant to the potential value of taking a statin while you are being treated for very late stage prostate cancer. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: cabazitaxel, data, interpretation, outcome, statin | 1 Comment »
Although it has nothing to do with prostate cancer in particular, there is an interesting article in this week’s issue of the New England Journal of Medicine that assesses how physicians interpret the published results of clinical trials of new drugs — based on the quality of the trials (their “rigor”) and who put up the money to carry the trial out (“funding”). … READ MORE …
Filed under: Uncategorized | Tagged: funding, interpretation, perception, quality, rigor, trial | Leave a comment »
THE "NEW" PROSTATE CANCER INFOLINK 